Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

DRAIC promotes growth of breast cancer by sponging miR-432-5p to upregulate SLBP


Mounting evidence suggests that lncRNAs can exert functions in cancer progression in multiple manners. In recent years, competing endogenous RNA (ceRNA) has been widely reported in human cancers as a lncRNA-dominant molecular pathway. The current study aimed at proving the role of lncRNA downregulated RNA in cancer (DRAIC) in breast cancer (BRCA) progression. To be specific, qRT-PCR assay was conducted to measure the expression of DRAIC and other downstream target genes. It was uncovered that DRAIC was expressed at a high level in BRCA cells. Functional analyses, including CCK-8, colony formation, and EdU assays demonstrated that DRAIC depletion suppressed BRCA cell proliferation. In addition, cell apoptosis was promoted due to DRAIC knockdown. The inhibitory effect of DRAIC reduction on BRCA cell migration and invasion was proven by transwell assays. Mechanistically, DRAIC was confirmed to predominantly distribute in the cytoplasm and could interact with miR-432-5p. In addition, stem-loop binding protein (SLBP) was verified to be a downstream target of miR-432-5p and was positively regulated by DRAIC. Taken together, DRAIC sponged miR-432-5p to enhance SLBP expression, by which malignant behaviors of BRCA cells were promoted. Our findings may help to provide a promising therapeutic target for BRCA patients.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: DRAIC is highly expressed in BRCA cells.
Fig. 2: DRAIC promotes proliferation, migration, and invasion of BRCA cells.
Fig. 3: DRAIC serves as miR-432-5p sponge in BRCA cells.
Fig. 4: SLBP is a direct target of miR-432-5p in BRCA cells.
Fig. 5: SLBP is involved in miR-432-5p-mediated BRCA cellular processes.
Fig. 6: DRAIC promotes BRCA cell growth by sponging miR-432-5p to upregulate SLBP.
Fig. 7: FOXP3 activates the transcription of DRAIC in BRCA cells.


  1. 1.

    Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B, et al. Primary and secondary prevention of breast cancer. Ann Agric Environ Med. 2017;24:549–53.

    Article  Google Scholar 

  2. 2.

    Ganz PA, Goodwin PJ. Breast cancer survivorship: where are we today? Adv Exp Med Biol. 2015;862:1–8.

    Article  Google Scholar 

  3. 3.

    Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730–56.

    Article  Google Scholar 

  4. 4.

    Merrill AY, White A, Howard-McNatt M. Paget’s Disease of the Breast: an Institutional Review and Surgical Management. Am Surg. 2017;83:e96–8.

    Article  Google Scholar 

  5. 5.

    Hunter KW, Crawford NP, Alsarraj J. Mechanisms of metastasis. Breast Cancer Res. 2008;10:S2. Suppl 1Suppl 1

    Article  Google Scholar 

  6. 6.

    Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017;50:33.

    Article  Google Scholar 

  7. 7.

    Wei JW, Huang K, Yang C, Kang CS. Non-coding RNAs as regulators in epigenetics (Review). Oncol Rep. 2017;37:3–9.

    Article  Google Scholar 

  8. 8.

    Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7–21.

    CAS  Article  Google Scholar 

  9. 9.

    Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–9.

    CAS  Article  Google Scholar 

  10. 10.

    Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Investig. 2016;126:2775–82.

    Article  Google Scholar 

  11. 11.

    Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154:26–46.

    CAS  Article  Google Scholar 

  12. 12.

    Liao B, Wang Z, Zhu Y, Wang M, Liu Y. Long noncoding RNA DRAIC acts as a microRNA-122 sponge to facilitate nasopharyngeal carcinoma cell proliferation, migration and invasion via regulating SATB1. Artif Cells Nanomed Biotechnol. 2019;47:3585–97.

    CAS  Article  Google Scholar 

  13. 13.

    Li F, Zhou X, Chen M, Fan W. Regulatory effect of LncRNA DRAIC/miR-149-5p/NFIB molecular network on autophagy of esophageal cancer cells and its biological behavior. Exp Mol Pathol. 2020;116:104491.

    CAS  Article  Google Scholar 

  14. 14.

    Zhao D, Dong JT. Upregulation of Long Non-Coding RNA DRAIC Correlates with Adverse Features of Breast Cancer. Non-coding RNA. 2018;4:39.

    Article  Google Scholar 

  15. 15.

    Sun M, Wu D, Zhou K, Li H, Gong X, Wei Q, et al. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Breast Cancer Res Treat. 2019;175:59–75.

    CAS  Article  Google Scholar 

  16. 16.

    Liu Y, Lu C, Zhou Y, Zhang Z, Sun L. Circular RNA hsa_circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis. Biochem Biophys Res Commun. 2018;502:358–63.

    CAS  Article  Google Scholar 

  17. 17.

    Yang G, Han B, Feng T. ZFAS1 knockdown inhibits viability and enhances cisplatin cytotoxicity by up-regulating miR-432-5p in glioma cells. Basic Clin Pharmacol Toxicol. 2019;125:518–26.

    CAS  Article  Google Scholar 

  18. 18.

    Wang Y, Huang H, Li Y. Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP. Artificial cells. Nanomed Biotechnol. 2019;47:1458–65.

    CAS  Google Scholar 

  19. 19.

    Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747–52.

    CAS  Article  Google Scholar 

  20. 20.

    Yeo SK, Guan JL. Breast Cancer: multiple subtypes within a tumor? Trends Cancer. 2017;3:753–60.

    CAS  Article  Google Scholar 

  21. 21.

    Zhang N, Cao C, Zhu Y, Liu P, Liu L, Lu K, et al. Primary breast lymphoma: a single center study. Oncol Lett. 2017;13:1014–8.

    Article  Google Scholar 

  22. 22.

    Zubor P, Kubatka P, Dankova Z, Gondova A, Kajo K, Hatok J, et al. miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer. Future Oncol (Lond, Engl). 2018;14:1847–67.

    CAS  Article  Google Scholar 

  23. 23.

    Tang Y, Wang Y, Kiani MF, Wang B. Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. Clin Breast Cancer. 2016;16:335–43.

    Article  Google Scholar 

  24. 24.

    Zhao W, Geng D, Li S, Chen Z, Sun M. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7:842–55.

    CAS  Article  Google Scholar 

  25. 25.

    Dong H, Hu J, Zou K, Ye M, Chen Y, Wu C, et al. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Mol Cancer. 2019;18:3.

    Article  Google Scholar 

  26. 26.

    Müller V, Oliveira-Ferrer L, Steinbach B, Pantel K, Schwarzenbach H. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer. Mol Oncol. 2019;13:1137–49.

    Article  Google Scholar 

  27. 27.

    Xiu B, Chi Y, Liu L, Chi W, Zhang Q, Chen J, et al. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2. Transcription 2019;18:187.

    CAS  Google Scholar 

  28. 28.

    Zhang K, Li Q, Kang X, Wang Y, Wang S. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme. Oncol Rep. 2016;36:2911–25.

    CAS  Article  Google Scholar 

  29. 29.

    Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52:710–8.

    Article  Google Scholar 

  30. 30.

    Ning S, Zhang J, Wang P, Zhi H, Wang J, Liu Y, et al. Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers. Nucleic Acids Res. 2016;44:D980–5. D1

    CAS  Article  Google Scholar 

  31. 31.

    Xu T, Lei T, Li SQ, Mai EH, Ding FH, Niu B. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p. World J Gastroenterol. 2020;26:1745–57.

    CAS  Article  Google Scholar 

  32. 32.

    Zhang J, Xu C, Gao Y, Wang Y, Ding Z, Zhang Y, et al. A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells. Front Oncol. 2020;10:215.

    CAS  Article  Google Scholar 

  33. 33.

    Hu C, Jiang R, Cheng Z, Lu Y, Gu L, Li H, et al. Ophiopogonin-B Suppresses Epithelial-mesenchymal Transition in Human Lung Adenocarcinoma Cells via the Linc00668/miR-432-5p/EMT Axis. J Cancer. 2019;10:2849–56.

    CAS  Article  Google Scholar 

Download references


We want to thank our laboratory staff for their contributions.


This study was supported by Construction of biological sample bank and clinical diagnosis and treatment information database of breast cancer, 2016YFC0901304.

Author information




SL, HJ and ZZ designed the study. SL, HJ and DW contributed to implementation of experiments. ZZ worked out also all technical details. DW was responsible for the numerical calculations. ZZ and DW analyzed the data. All authors participated in the discussion of the results and contributed to the final paper.

Corresponding author

Correspondence to Di Wu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, S., Jia, H., Zhang, Z. et al. DRAIC promotes growth of breast cancer by sponging miR-432-5p to upregulate SLBP. Cancer Gene Ther (2021).

Download citation


Quick links